相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression
Helmut Bonkhoff
PROSTATE (2018)
Liver X receptors in lipid signalling and membrane homeostasis
Bo Wang et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
The current evidence on statin use and prostate cancer prevention: are we there yet?
Mahmoud A. Alfaqih et al.
NATURE REVIEWS UROLOGY (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
Philip Cornford et al.
EUROPEAN UROLOGY (2017)
Activation of liver X receptor suppresses angiogenesis via induction of ApoD
Chih-Jen Lai et al.
FASEB JOURNAL (2017)
Liver X receptor activation inhibits PC-3 prostate cancer cells via the beta-catenin pathway
Kuang Youlin et al.
PATHOLOGY RESEARCH AND PRACTICE (2017)
The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer
Lauren C. Harshman et al.
PROSTATE (2017)
Prognostic Role of Preoperative Serum Lipid Levels in Patients Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer
Marian S. Wettstein et al.
PROSTATE (2017)
Dendrogenin A drives LXR to trigger lethal autophagy in cancers
Gregory Segala et al.
NATURE COMMUNICATIONS (2017)
Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells
Haojun Xiong et al.
ONCOTARGET (2017)
Molecular mechanism of estrogen-estrogen receptor signaling
Pelin Yasar et al.
REPRODUCTIVE MEDICINE AND BIOLOGY (2017)
The cholesterol metabolite 27-hydroxycholesterol stimulates cell proliferation via ERβ in prostate cancer cells
Shaneabbas Raza et al.
CANCER CELL INTERNATIONAL (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils
Todd G. Kirchgessner et al.
CELL METABOLISM (2016)
Identification and in Vivo Evaluation of Liver X Receptor β-Selective Agonists for the Potential Treatment of Alzheimer's Disease
Shawn J. Stachel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Nicholas D. James et al.
LANCET (2016)
Once and for all, LXRα and LXRβ are gatekeepers of the endocrine system
Salwan Maqdasy et al.
MOLECULAR ASPECTS OF MEDICINE (2016)
5-Alpha-Reductase Inhibitors and Combination Therapy
Claudius Fuellhase et al.
UROLOGIC CLINICS OF NORTH AMERICA (2016)
Research Resources for Nuclear Receptor Signaling Pathways
Neil J. McKenna
MOLECULAR PHARMACOLOGY (2016)
Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies
Shanliang Zhong et al.
CANCER TREATMENT REVIEWS (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer (vol 161, pg 1215, 2015)
Dan Robinson et al.
CELL (2015)
The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancer
Daniel Tamae et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Observational studies and the natural history of screen-detected prostate cancer
Peter C. Albertsen
CURRENT OPINION IN UROLOGY (2015)
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Christopher J. Sweeney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Divergent Effect of Liver X Receptor Agonists on Prostate-specific Antigen Expression Is Dependent on Androgen Receptor in Prostate Carcinoma Cells
Ke-Hung Tsui et al.
PROSTATE (2015)
Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer
Lauren C. Harshman et al.
JAMA ONCOLOGY (2015)
A structural perspective on nuclear receptors as targets of environmental compounds
Vanessa Delfosse et al.
ACTA PHARMACOLOGICA SINICA (2015)
Identification of interferon-γ as a new molecular target of liver X receptor
Qixue Wang et al.
BIOCHEMICAL JOURNAL (2014)
Broad-Spectrum Therapeutic Suppression of Metastatic Melanoma through Nuclear Hormone Receptor Activation
Nora Pencheva et al.
CELL (2014)
Nuclear Receptors, RXR, and the Big Bang
Ronald M. Evans et al.
CELL (2014)
Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness
Shuhua Yue et al.
CELL METABOLISM (2014)
LXR Agonist Regulates the Carcinogenesis of PCa via the SOCS3 Pathway
Weihua Fu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Looking at nuclear receptors from a new angle
Christine Helsen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man
Naomi L. Sharma et al.
CANCER CELL (2013)
A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer
Kai-Hsiung Chang et al.
CELL (2013)
Steroidogenic Enzyme AKR1C3 Is a Novel Androgen Receptor-Selective Coactivator that Promotes Prostate Cancer Growth
Muralimohan Yepuru et al.
CLINICAL CANCER RESEARCH (2013)
Distinct Function of Estrogen Receptor α in Smooth Muscle and Fibroblast Cells in Prostate Development
Spencer Vitkus et al.
MOLECULAR ENDOCRINOLOGY (2013)
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
C. Parker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Lack of Liver X Receptors Leads to Cell Proliferation in a Model of Mouse Dorsal Prostate Epithelial Cell
Julie Dufour et al.
PLOS ONE (2013)
Liver X Receptors Protect from Development of Prostatic Intra-Epithelial Neoplasia in Mice
Aurelien J. C. Pommier et al.
PLOS GENETICS (2013)
The prognostic significance of loss of the androgen receptor and neuroendocrine differentiation in prostate biopsy specimens among castration-resistant prostate cancer patients
Akira Komiya et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Androgen receptor genomic regulation
Hong-Jian Jin et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2013)
FOXA1 Promotes Tumor Progression in Prostate Cancer and Represents a Novel Hallmark of Castration-Resistant Prostate Cancer
Josefine Gerhardt et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Liver X Receptor Activation Reduces Angiogenesis by Impairing Lipid Raft Localization and Signaling of Vascular Endothelial Growth Factor Receptor-2
Alessio Noghero et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Distinct Patterns of Dysregulated Expression of Enzymes Involved in Androgen Synthesis and Metabolism in Metastatic Prostate Cancer Tumors
Nicholas Mitsiades et al.
CANCER RESEARCH (2012)
Aggressive Prostate Cancer Is Prevented in ERαKO Mice and Stimulated in ERβKO TRAMP Mice
Anna Slusarz et al.
ENDOCRINOLOGY (2012)
Lxrα Regulates the Androgen Response in Prostate Epithelium
Emilie Viennois et al.
ENDOCRINOLOGY (2012)
Loss of epithelial oestrogen receptor α inhibits oestrogen-stimulated prostate proliferation and squamous metaplasia via in vivo tissue selective knockout models
Ming Chen et al.
JOURNAL OF PATHOLOGY (2012)
Androgen receptor (AR) aberrations in castration-resistant prostate cancer
Kati K. Waltering et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
Matthew R. Smith et al.
LANCET (2012)
Aldo-keto Reductase Family 1 Member C3 (AKR1C3) Is a Biomarker and Therapeutic Target for Castration-Resistant Prostate Cancer
Agus Rizal A. H. Hamid et al.
MOLECULAR MEDICINE (2012)
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Almut Schulze et al.
NATURE (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
Charles E. Massie et al.
EMBO JOURNAL (2011)
Targeting liver X receptors in human health: deadlock or promising trail?
Emilie Viennois et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Cross-talk between the Androgen Receptor and the Liver X Receptor IMPLICATIONS FOR CHOLESTEROL HOMEOSTASIS
James Robert Krycer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal
Sanaz Memarzadeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Tissue-Specific Liver X Receptor Activation Promotes Macrophage Reverse Cholesterol Transport In Vivo
Tomoyuki Yasuda et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Is statin use associated with prostate cancer aggressiveness?
Stacy Loeb et al.
BJU INTERNATIONAL (2010)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling
Martin Puhr et al.
ENDOCRINE-RELATED CANCER (2010)
High-Density Lipoprotein Induces Proliferation and Migration of Human Prostate Androgen-Independent Cancer Cells by an ABCA1-Dependent Mechanism
Yoshitaka Sekine et al.
MOLECULAR CANCER RESEARCH (2010)
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian de Bono et al.
LANCET (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells
A. J. C. Pommier et al.
ONCOGENE (2010)
Estrogen Sulfotransferases in Breast and Endometrial Cancers
Jorge Raul Pasqualini
STEROID ENZYMES AND CANCER (2009)
Citrate transport and metabolism in mammalian cells Prostate epithelial cells and prostate cancer
Maria E. Mycielska et al.
BIOESSAYS (2009)
Defects of Prostate Development and Reproductive System in the Estrogen Receptor-alpha Null Male Mice
Ming Chen et al.
ENDOCRINOLOGY (2009)
Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer
Gerhardt Attard et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Stromal growth and epithelial cell proliferation in ventral prostates of liver X receptor knockout mice
Hyun-Jin Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Unique Patterns of Molecular Profiling Between Human Prostate Cancer LNCaP and PC-3 Cells
Mikhail G. Dozmorov et al.
PROSTATE (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
Laurence Klotz et al.
BJU INTERNATIONAL (2008)
Androgen and prostate cancer: Is the hypothesis dead?
Ann W. Hsing et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
R. Bruce Montgomery et al.
CANCER RESEARCH (2008)
Androgen deprivation by activating the liver X receptor
Jung Hoon Lee et al.
ENDOCRINOLOGY (2008)
The role of estrogens and estrogen receptors in normal prostate growth and disease
Gail S. Prins et al.
STEROIDS (2008)
Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor
Haibiao Gong et al.
MOLECULAR ENDOCRINOLOGY (2007)
Macrophages from irradiated tumors express higher levels of iNOS, Arginase-I and COX-2, and promote tumor growth
Chien-Sheng Tsai et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Inflammation in prostate carcinogenesis
Angelo M. De Marzo et al.
NATURE REVIEWS CANCER (2007)
Statin drugs and risk of advanced prostate cancer
Elizabeth A. Platz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist
Chih-pin Chuu et al.
CANCER RESEARCH (2006)
A retrospective study of the time to clinical endpoints for advanced prostate cancer
N Sharifi et al.
BJU INTERNATIONAL (2005)
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer
MR Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer
KP Weinfurt et al.
ANNALS OF ONCOLOGY (2005)
Local aromatase expression in human prostate is altered in malignancy
SJ Ellem et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The androgen axis in recurrent prostate cancer
JL Mohler et al.
CLINICAL CANCER RESEARCH (2004)
Estrogen receptor β regulates epithelial cellular differentiation in the mouse ventral prostate
O Imamov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer
F Saad et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability
IK Mellinghoff et al.
CANCER CELL (2004)
Adrenal androgens and intracrinology
F Labrie
SEMINARS IN REPRODUCTIVE MEDICINE (2004)
Role of estrogens in development of prostate cancer
PL Härkönen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Gene expression profiling identifies liver X receptor alpha as an estrogen-regulated gene in mouse adipose tissue
L Lundholm et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2004)
Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells
J Fukuchi et al.
CANCER RESEARCH (2004)
Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells
J Fukuchi et al.
CANCER RESEARCH (2004)
Crosstalk between LXR and Toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism
A Castrillo et al.
MOLECULAR CELL (2003)
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
SB Joseph et al.
NATURE MEDICINE (2003)
Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol
L Labrecque et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Generation and characterization of androgen receptor knockout (ARKO) mice:: An in vivo model for the study of androgen functions in selective tissues
SY Yeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions
CA Heinlein et al.
MOLECULAR ENDOCRINOLOGY (2002)
17-β-estradiol regulates expression of genes that function in macrophage activation and cholesterol homeostasis
PR Kramer et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer
JV Swinnen et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
A prospective study on intake of animal products and risk of prostate cancer
DS Michaud et al.
CANCER CAUSES & CONTROL (2001)
Comparative studies of the estrogen receptors β and α and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma
I Leav et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Estrogen receptors α and β in the normal, hyperplastic and carcinomatous human prostate
M Royuela et al.
JOURNAL OF ENDOCRINOLOGY (2001)
Her-2-neu expression and progression toward androgen independence in human prostate cancer
S Signoretti et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Metastatic patterns of prostate cancer:: An autopsy study of 1,589 patients
L Bubendorf et al.
HUMAN PATHOLOGY (2000)
分享论文
